Literature DB >> 31149832

Automated Machine Learning Diagnostic Support System as a Computational Biomarker for Detecting Drug-Induced Liver Injury Patterns in Whole Slide Liver Pathology Images.

Munish Puri1.   

Abstract

Drug-induced liver injury (DILI) is a challenging disease to diagnose, a leading cause of acute liver failure, and responsible for drug withdrawal from the market. There is no symptom, no biomarker or test for detection, no therapy, but discontinuation of the drug. Pharmaceutical companies spend huge money, time, and scientific research efforts to test DILI effects and drug efficacy. A preclinical diagnostic support system is designed and proposed for DILI detection and classification on liver biopsy histopathology images. Heterogeneity features and automated machine learning (AutoML) models were tested to classify DILI injury patterns on whole slide image. Fractal and lacunarity values were used to detect hepatocellular necrotic injury patterns caused on a rat liver (in vivo) by 10 drugs at four dose levels. Correlations between fractal and lacunarity values were statistically analyzed for the 10 drugs; the Pearson correlation (r = 0.9809), p-value (1.6612E-06), and R2 (0.9582) were found to be high in the case of carbon tetrachloride. The AutoML model was tested to understand the injury patterns on a subset of 1,277 histology images. The AutoML algorithm was able to classify necrotic injury patterns accurately with an average precision of 98.6% on a score threshold of 0.5.

Entities:  

Keywords:  automated machine learning; computational biomarker; diagnostic support system; drug-induced liver injury; feature-based DILI detection

Mesh:

Substances:

Year:  2019        PMID: 31149832      PMCID: PMC6998050          DOI: 10.1089/adt.2019.919

Source DB:  PubMed          Journal:  Assay Drug Dev Technol        ISSN: 1540-658X            Impact factor:   1.738


  35 in total

1.  How artificial intelligence is changing drug discovery.

Authors:  Nic Fleming
Journal:  Nature       Date:  2018-05       Impact factor: 49.962

2.  Development and validation of a clinical scale for the diagnosis of drug-induced hepatitis.

Authors:  V A Maria; R M Victorino
Journal:  Hepatology       Date:  1997-09       Impact factor: 17.425

3.  ACG Clinical Guideline: the diagnosis and management of idiosyncratic drug-induced liver injury.

Authors:  Naga P Chalasani; Paul H Hayashi; Herbert L Bonkovsky; Victor J Navarro; William M Lee; Robert J Fontana
Journal:  Am J Gastroenterol       Date:  2014-06-17       Impact factor: 10.864

Review 4.  Acute liver failure due to drugs.

Authors:  Robert J Fontana
Journal:  Semin Liver Dis       Date:  2008-05       Impact factor: 6.115

5.  Using controlled clinical trials to learn more about acute drug-induced liver injury.

Authors:  Paul B Watkins; Paul J Seligman; John S Pears; Mark I Avigan; John R Senior
Journal:  Hepatology       Date:  2008-11       Impact factor: 17.425

6.  Deep Learning for Drug Discovery and Cancer Research: Automated Analysis of Vascularization Images.

Authors:  Gregor Urban; Kevin M Bache; Duc Phan; Agua Sobrino; Alexander Konstantinovich Shmakov; Stephanie J Hachey; Chris Hughes; Pierre Baldi
Journal:  IEEE/ACM Trans Comput Biol Bioinform       Date:  2018-05-29       Impact factor: 3.710

7.  Deep learning based tissue analysis predicts outcome in colorectal cancer.

Authors:  Dmitrii Bychkov; Nina Linder; Riku Turkki; Stig Nordling; Panu E Kovanen; Clare Verrill; Margarita Walliander; Mikael Lundin; Caj Haglund; Johan Lundin
Journal:  Sci Rep       Date:  2018-02-21       Impact factor: 4.379

8.  A deep learning approach to automate refinement of somatic variant calling from cancer sequencing data.

Authors:  Benjamin J Ainscough; Erica K Barnell; Peter Ronning; Katie M Campbell; Alex H Wagner; Todd A Fehniger; Gavin P Dunn; Ravindra Uppaluri; Ramaswamy Govindan; Thomas E Rohan; Malachi Griffith; Elaine R Mardis; S Joshua Swamidass; Obi L Griffith
Journal:  Nat Genet       Date:  2018-11-05       Impact factor: 38.330

9.  Classification and mutation prediction from non-small cell lung cancer histopathology images using deep learning.

Authors:  Nicolas Coudray; Paolo Santiago Ocampo; Theodore Sakellaropoulos; Navneet Narula; Matija Snuderl; David Fenyö; Andre L Moreira; Narges Razavian; Aristotelis Tsirigos
Journal:  Nat Med       Date:  2018-09-17       Impact factor: 53.440

Review 10.  Machine learning applications in cancer prognosis and prediction.

Authors:  Konstantina Kourou; Themis P Exarchos; Konstantinos P Exarchos; Michalis V Karamouzis; Dimitrios I Fotiadis
Journal:  Comput Struct Biotechnol J       Date:  2014-11-15       Impact factor: 7.271

View more
  1 in total

Review 1.  The Promise of AI for DILI Prediction.

Authors:  Andreu Vall; Yogesh Sabnis; Jiye Shi; Reiner Class; Sepp Hochreiter; Günter Klambauer
Journal:  Front Artif Intell       Date:  2021-04-14
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.